Efficacy of PD‐1/PD‐L1 inhibitors in patients with non‐small cell lung cancer and brain metastases: A real‐world retrospective study in China

Abstract Background There is only limited knowledge of the treatment responses and clinical outcomes of immune checkpoint inhibitors (ICIs) in driver gene‐negative non‐small cell lung cancer (NSCLC) patients with brain metastases (BM). This study aims to assess the efficacy of immunotherapy in these...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jiamin Sheng, Hui Li, Xiaoqing Yu, Sizhe Yu, Kaiyan Chen, Guoqiang Pan, Mingying Xie, Na Li, Zichao Zhou, Yun Fan
Format: article
Langue:EN
Publié: Wiley 2021
Sujets:
Accès en ligne:https://doaj.org/article/8b84efb8272d4cd7ac8a2e3adc9d5dae
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!